Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Picture this: You’re an astronaut on a space mission, and you’ve just stepped out of your spacecraft onto the surface of a mysterious new planet. Your eyesight is crucial to your survival in this alien environment, as you must rely…

Pseudoexfoliation syndrome (PEX) is a systemic disorder characterized by the abnormal production and accumulation of fibrous extracellular material in various parts of the body, including the eyes. This condition is most commonly known for its impact on ocular health, where…

SpyGlass Pharma has successfully closed a Series C financing round, raising $90 million. RA Capital Management led the funding round, joined by existing investors New Enterprise Associates (NEA) and Vensana Capital, as well as new investors Samsara BioCapital and Vertex…

What Is Corneal Edema? Corneal edema refers to the swelling of the cornea, the transparent, dome-shaped layer at the front of the eye. This swelling typically results from an abnormal accumulation of fluid within the corneal layers, disrupting its usual…

A cataract is a pathologic condition in which the eye’s lens opacifies, resulting in changes to vision that can range from color changes and blurriness to halos around lights and, in the worst case scenario, blindness. A senile cataract, in…

Trabeculectomy is a surgical procedure primarily used to treat glaucoma, a group of eye conditions characterized by damage to the optic nerve, often due to abnormally high pressure in the eye. As one of the most commonly performed surgeries for…

Sight Sciences released study findings demonstrating that patients with glaucoma who had undergone procedures using their OMNI Surgical System technology had a greater average reduction in the usage of intraocular pressure-lowering medication compared to those who had received only minimally…

On Monday, the US Food and Drug Administration (FDA) took action by sending warning letters to several companies, including CVS and Walgreens, due to concerns regarding the manufacturing and marketing of unapproved eye products. According to the FDA, these products…

Carl Zeiss Meditec AG announced that they have entered into an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from Eurazeo SE, based in Paris, France. The deal is worth €985 million (nearly…

Sight Sciences expressed its support for the decision made by five Medicare Administrative Contractors to withdraw their previously announced final local coverage determinations (LCDs) for Micro-Invasive Glaucoma Surgery, originally slated to become effective on January 29, 2024. The five MACs—WPS…